U.S. markets closed

Penumbra, Inc. (PEN)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
266.23+1.80 (+0.68%)
At close: 4:00PM EDT

Penumbra, Inc.

One Penumbra Place
Alameda, CA 94502
United States
510 748 3200

IndustryMedical Devices
Full Time Employees3,300

Key Executives

NameTitlePayExercisedYear Born
Mr. Adam ElsesserCo-Founder, Chairman, Pres & CEO219.03kN/A1962
Ms. Maggie S. YuenChief Financial Officer519.04kN/A1972
Mr. Lambert ShiuChief Accounting Officer413.21kN/A1980
Ms. Johanna RobertsExec. VP, Gen. Counsel & Sec.441.93kN/A1972
Ms. Lynn RothmanExec. VP & Chief Bus. Officer528.89k6.9M1961
Dr. Arani BoseCo-Founder, Chief Innovator & DirectorN/AN/A1962
Mr. Ben SorciExec. VP of OperationsN/AN/AN/A
Mr. Corey L. Teigen M.D.Chief Scientific OfficerN/AN/AN/A
Ms. Jee Hamlyn-HarrisInvestor Relations OfficerN/AN/AN/A
Ms. Kathleen KiddSr. VP of Quality & ComplianceN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; immersive virtual reality and display system that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand name, as well as a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and POD Packing Coil brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.

Corporate Governance

Penumbra, Inc.’s ISS Governance QualityScore as of July 1, 2021 is 8. The pillar scores are Audit: 8; Board: 7; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.